NO20020463L - Nye hydantoin-, tiohydantoin-, pyrimidindion- og tioksopyrimidinonderivater, fremstillingsmetode og anvendelse sommedikamenter - Google Patents

Nye hydantoin-, tiohydantoin-, pyrimidindion- og tioksopyrimidinonderivater, fremstillingsmetode og anvendelse sommedikamenter

Info

Publication number: NO20020463L
Authority: NO; Norway
Prior art keywords: thioxopyrimidinone; pyrimidinedione; thiohydantoin; drugs; derivatives
Prior art date: 1999-07-30

Application number

NO20020463A

Other languages

English (en)

Other versions

NO323605B1 (no

NO20020463D0 (no

Inventor

Lydie Poitout

Christophe Thurieau

Valerie Brault

Original Assignee

Sod Conseils Rech Applic

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-30

Filing date

2002-01-29

Publication date

2002-02-13

2002-01-29 Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic

2002-01-29 Publication of NO20020463D0 publication Critical patent/NO20020463D0/no

2002-02-13 Publication of NO20020463L publication Critical patent/NO20020463L/no

2007-06-18 Publication of NO323605B1 publication Critical patent/NO323605B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Immunology (AREA)
Hematology (AREA)
Endocrinology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Oncology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Otolaryngology (AREA)
Communicable Diseases (AREA)

NO20020463A 1999-07-30 2002-01-29 Nye tioksotetrahydropyrimidinon- og tiohydantoinderivater, preparater av disse, fremstillingsmetode og anvendelse derav for fremstilling av medikamenter for behandling av sykdommer NO323605B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9909886A FR2796945B1 (fr)	1999-07-30	1999-07-30	Nouveaux derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinones, leurs procedes de preparation et leur application a titre de medicaments
PCT/FR2000/002164 WO2001009090A2 (fr)	1999-07-30	2000-07-28	Derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinoneses, leurs procedes de preparation et leur application a titre de medicaments

Publications (3)

Publication Number	Publication Date
NO20020463D0 NO20020463D0 (no)	2002-01-29
NO20020463L true NO20020463L (no)	2002-02-13
NO323605B1 NO323605B1 (no)	2007-06-18

Family

ID=9548689

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20020463A NO323605B1 (no)	1999-07-30	2002-01-29	Nye tioksotetrahydropyrimidinon- og tiohydantoinderivater, preparater av disse, fremstillingsmetode og anvendelse derav for fremstilling av medikamenter for behandling av sykdommer

Country Status (24)

Country	Link
US (3)	US6759415B1 (no)
EP (1)	EP1246807B1 (no)
JP (1)	JP2003518011A (no)
KR (1)	KR100712587B1 (no)
CN (1)	CN1177828C (no)
AR (1)	AR024939A1 (no)
AT (1)	ATE308525T1 (no)
AU (1)	AU779357B2 (no)
BR (1)	BR0012852A (no)
CA (1)	CA2380070C (no)
CZ (1)	CZ2002301A3 (no)
DE (1)	DE60023747T2 (no)
DK (1)	DK1246807T3 (no)
ES (1)	ES2252051T3 (no)
FR (1)	FR2796945B1 (no)
HK (1)	HK1052510B (no)
HU (1)	HUP0202989A3 (no)
IL (1)	IL147744A0 (no)
MX (1)	MXPA02001016A (no)
NO (1)	NO323605B1 (no)
NZ (1)	NZ516718A (no)
PL (1)	PL364726A1 (no)
RU (1)	RU2277093C2 (no)
WO (1)	WO2001009090A2 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0011071D0 (en) *	2000-05-08	2000-06-28	Novartis Ag	Organic compounds
JP4711523B2 (ja) *	2001-02-13	2011-06-29	日本臓器製薬株式会社	低アルブミン血症改善剤
CA2450446A1 (en) *	2001-06-25	2003-01-03	Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R	Pharmaceutical compositions which inhibit proliferation of pituitary adenomas and method of use thereof
FR2832710B1 (fr) *	2001-11-28	2004-09-03	Sod Conseils Rech Applic	Derives de 5-sulfanyl-4h-1,2,4-triazoles et leur utilisation en tant que medicaments
AU2002361345B8 (en) *	2001-11-28	2008-06-26	Ipsen Pharma S.A.S.	5-sulphanyl-4H-1,2,4-triazole derivatives and their use as medicine
WO2003057214A1 (en)	2001-12-28	2003-07-17	Somatocor Pharmaceuticals, Inc.	Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands
HRP20050053A2 (en) *	2002-09-19	2005-04-30	Solvay Pharmaceuticals B.V.	1 h-1,2,4-triazole-3-carboxamide derivatives as cannabinoid-cb1 receptor ligands
FR2850652B1 (fr) *	2003-01-31	2008-05-30	Aventis Pharma Sa	Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
US7354933B2 (en) *	2003-01-31	2008-04-08	Aventis Pharma Sa	Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
DE10325813B4 (de) *	2003-06-06	2007-12-20	Universitätsklinikum Freiburg	Prophylaxe und/oder Therapie bei der portalen Hypertonie
EP1621535A1 (en) *	2004-07-27	2006-02-01	Aventis Pharma S.A.	Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
EP1621539A1 (en) *	2004-07-27	2006-02-01	Aventis Pharma S.A.	Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
EP1621536A1 (en) *	2004-07-27	2006-02-01	Aventis Pharma S.A.	Amino cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
RS52274B2 (sr) *	2005-05-13	2018-05-31	Univ California	Jedinjenje diarilhidantoina
FR2896503B1 (fr) *	2006-01-23	2012-07-13	Aventis Pharma Sa	Nouveaux derives soufres d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
FR2896504B1 (fr) *	2006-01-23	2012-07-13	Aventis Pharma Sa	Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
EP2061767B1 (de)	2006-08-08	2014-12-17	Sanofi	Arylaminoaryl-alkyl-substituierte Imidazolidin-2,4-dione, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und ihre Verwendung
US8889709B2 (en)	2006-09-21	2014-11-18	Probiodrug Ag	Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions
US9277737B2 (en)	2006-09-21	2016-03-08	Probiodrug Ag	Mouse models carrying a knock-out mutation of the QPCTL-gene
US20080249083A1 (en)	2006-09-21	2008-10-09	Probiodrug Ag	Novel genes related to glutaminyl cyclase
US8710086B2 (en)	2009-04-09	2014-04-29	Medivation Technologies, Inc.	Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods of use thereof
EP2776405A1 (en) *	2011-11-11	2014-09-17	Pfizer Inc	2-thiopyrimidinones
WO2016036796A1 (en) *	2014-09-03	2016-03-10	Genzyme Corporation	Cyclic urea compounds as tropomyosin-related kinase (trk) inhibitors
CN117120436A (zh) *	2021-03-30	2023-11-24	苏州开拓药业股份有限公司	一种一步法合成乙内酰硫脲衍生物的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2693461B1 (fr) *	1992-07-08	1994-09-02	Roussel Uclaf	Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
WO1997043278A1 (en) *	1996-05-14	1997-11-20	Novo Nordisk A/S	Somatostatin agonists and antagonists
CA2238331C (en) *	1996-09-24	2003-02-25	Taiho Pharmaceutical Co., Ltd.	Cancerous metastasis inhibitors containing uracil derivatives
US6025372A (en) *	1997-04-04	2000-02-15	Merck & Co., Inc.	Somatostatin agonists
PT1019050E (pt)	1997-06-24	2002-09-30	Novo Nordisk As	Utilizacao de agonisticos e de antagonisticos de somatostatina para o tratamento de doencas associadas ao olho
CN1169808C (zh)	1998-06-12	2004-10-06	研究及应用科学协会股份有限公司	β-咔啉化合物
AU746963B2 (en) *	1998-06-12	2002-05-09	Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.)	Imidazolyl derivatives
CN1200000C (zh)	1998-06-16	2005-05-04	研究及应用科学协会股份有限公司	促生长素抑制素类似物

1999
- 1999-07-30 FR FR9909886A patent/FR2796945B1/fr not_active Expired - Fee Related
2000
- 2000-07-25 AR ARP000103851A patent/AR024939A1/es active IP Right Grant
- 2000-07-28 MX MXPA02001016A patent/MXPA02001016A/es active IP Right Grant
- 2000-07-28 JP JP2001514294A patent/JP2003518011A/ja active Pending
- 2000-07-28 HK HK03104848.3A patent/HK1052510B/zh not_active IP Right Cessation
- 2000-07-28 HU HU0202989A patent/HUP0202989A3/hu unknown
- 2000-07-28 DE DE60023747T patent/DE60023747T2/de not_active Expired - Lifetime
- 2000-07-28 ES ES00958634T patent/ES2252051T3/es not_active Expired - Lifetime
- 2000-07-28 AU AU70091/00A patent/AU779357B2/en not_active Ceased
- 2000-07-28 NZ NZ516718A patent/NZ516718A/xx not_active IP Right Cessation
- 2000-07-28 AT AT00958634T patent/ATE308525T1/de not_active IP Right Cessation
- 2000-07-28 EP EP00958634A patent/EP1246807B1/fr not_active Expired - Lifetime
- 2000-07-28 CN CNB008110654A patent/CN1177828C/zh not_active Expired - Fee Related
- 2000-07-28 WO PCT/FR2000/002164 patent/WO2001009090A2/fr not_active Ceased
- 2000-07-28 DK DK00958634T patent/DK1246807T3/da active
- 2000-07-28 KR KR1020027001224A patent/KR100712587B1/ko not_active Expired - Fee Related
- 2000-07-28 CA CA2380070A patent/CA2380070C/fr not_active Expired - Fee Related
- 2000-07-28 PL PL00364726A patent/PL364726A1/xx not_active Application Discontinuation
- 2000-07-28 RU RU2002105024/04A patent/RU2277093C2/ru not_active IP Right Cessation
- 2000-07-28 CZ CZ2002301A patent/CZ2002301A3/cs unknown
- 2000-07-28 IL IL14774400A patent/IL147744A0/xx not_active IP Right Cessation
- 2000-07-28 US US10/048,144 patent/US6759415B1/en not_active Expired - Fee Related
- 2000-07-28 BR BR0012852-0A patent/BR0012852A/pt not_active Application Discontinuation
2002
- 2002-01-29 NO NO20020463A patent/NO323605B1/no not_active IP Right Cessation
2004
- 2004-03-30 US US10/813,139 patent/US7199145B2/en not_active Expired - Fee Related
2006
- 2006-06-01 US US11/444,769 patent/US7332517B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE60023747D1 (de)	2005-12-08
WO2001009090A2 (fr)	2001-02-08
ES2252051T3 (es)	2006-05-16
WO2001009090A3 (fr)	2002-08-08
CZ2002301A3 (cs)	2002-08-14
NO323605B1 (no)	2007-06-18
JP2003518011A (ja)	2003-06-03
NO20020463D0 (no)	2002-01-29
AR024939A1 (es)	2002-10-30
BR0012852A (pt)	2002-04-30
CN1177828C (zh)	2004-12-01
CA2380070A1 (fr)	2001-02-08
US7199145B2 (en)	2007-04-03
HK1052510B (zh)	2005-04-29
DE60023747T2 (de)	2006-08-03
FR2796945A1 (fr)	2001-02-02
IL147744A0 (en)	2002-08-14
RU2277093C2 (ru)	2006-05-27
US20070021420A1 (en)	2007-01-25
DK1246807T3 (da)	2006-03-20
EP1246807B1 (fr)	2005-11-02
KR20020025203A (ko)	2002-04-03
EP1246807A2 (fr)	2002-10-09
HK1052510A1 (en)	2003-09-19
AU779357B2 (en)	2005-01-20
HUP0202989A3 (en)	2003-02-28
HUP0202989A2 (hu)	2002-12-28
US7332517B2 (en)	2008-02-19
AU7009100A (en)	2001-02-19
MXPA02001016A (es)	2002-08-12
CN1399631A (zh)	2003-02-26
PL364726A1 (en)	2004-12-13
US6759415B1 (en)	2004-07-06
KR100712587B1 (ko)	2007-05-02
FR2796945B1 (fr)	2002-06-28
ATE308525T1 (de)	2005-11-15
NZ516718A (en)	2003-04-29
CA2380070C (fr)	2010-11-09
US20040209908A1 (en)	2004-10-21

Publication	Publication Date	Title
NO20020463D0 (no)	2002-01-29	Nye hydantoin-, tiohydantoin-, pyrimidindion- og tioksopyrimidinonderivater, fremstillingsmetode og anvendelse sommedikamenter
NO20021689L (no)	2002-05-30	5-leddede heterocykliske derivater, fremstilling derav og anvendelse som medikamenter
EE200200118A (et)	2003-04-15	Terapeutilised kinasoliini derivaadid, nende valmistamise meetod ning kasutamine
NO20024176L (no)	2002-10-29	Farmasöytiske preparater inneholder derivater av 3-amino- azetidin, de nye derivater og deres fremstilling
NO20015362L (no)	2001-11-02	Heterocyklisk substituerte benzimidazoler, deres fremstilling og anvendelse derav
FR16C0042I2 (fr)	2017-03-17	Derives de composes heterocycliques et medicaments
NO20013736D0 (no)	2001-07-30	Pyrazolkarboksylsyrederivater, deres fremstilling og farmasöytiske preparater inneholdende de samme
NO20016185L (no)	2001-12-18	Bicykliske heterocykler, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for fremstillingderav
EE200100431A (et)	2002-12-16	16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
NO20051493D0 (no)	2005-03-21	Imidazolpyridiner og fremgangsmater for fremstilling og anvendelse av de samme
NO20032726D0 (no)	2003-06-16	Kinazolinderivater, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for fremstilling derav
PL377811A1 (pl)	2006-02-20	Nowe cykliczne pochodne mocznika, sposób ich wytwarzania i ich zastosowanie farmaceutyczne jako inhibitorów kinazy
NO20012567D0 (no)	2001-05-25	Azepinoindolderivater, fremstilling og anvendelse derav
NO20013560L (no)	2001-09-18	Polymorfer av telmisartan, fremgangsmåter for fremstilling derav og anvendelse derav for fremstilling av et medikament
NO20015054L (no)	2001-12-14	Legemidler omfattende inhibitorer av cellevolumregulert human Kinase H-SGK
IS6661A (is)	2002-12-19	Bensimídasólafleiður, framleiðsla þeirra og meðferðarleg notkun
NO20040268L (no)	2004-03-23	Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen
DK1414816T3 (da)	2005-04-11	Stabil polymorf af flibanserin, teknisk fremgangsmåde til fremstilling deraf og anvendelse deraf til lægemiddelfremstilling
PT1230230E (pt)	2003-12-31	Derivados de indeno-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorexigenico
EE200100422A (et)	2002-12-16	Epotilooni derivaadid, nende valmistamismeetod jafarmatseutiline kasutamine
NO20026212D0 (no)	2002-12-23	Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen
NO20032234D0 (no)	2003-05-16	Nye imidazolderivater, deres fremstilling og anvendelse
DK1178799T3 (da)	2003-12-22	Gastrobeskyttede mikrogranula, fremgangsmåde til opnåelse af samme og farmaceutiske præparater
NO20014224D0 (no)	2001-08-31	4-heterocyklysulfonamidyl-6-metoksy-5-(2-metoksy-fenoksy)-2- pyridyl-pyrimidinderivater, fremstilling derav og anvendelse somendotelin reseptor antagonister
NO992976D0 (no)	1999-06-17	Heterocykliske karboksylsyre-derivater, fremstilling og anvendelse derav som endothelinreseptor-antagonister

Legal Events

Date	Code	Title	Description
2012-02-20	MM1K	Lapsed by not paying the annual fees